In Vitro Diagnostic Packaging Market To Reach $12.53 Billion By 2030

In Vitro Diagnostic Packaging Market Growth & Trends

The global in vitro diagnostic packaging market size is anticipated to reach USD 12.53 billion by 2030 and is anticipated to expand at a CAGR of 5.1% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic and infectious diseases is a major driver for the IVD packaging market. With rising cases of diabetes, cardiovascular diseases, and cancers, demand for diagnostic tests has surged, necessitating reliable and efficient packaging solutions. Additionally, the growing adoption of point-of-care (POC) testing devices requires robust packaging to ensure stability during transport and storage.

Technological advancements in diagnostic devices are also fueling market growth. Innovations such as microfluidics, lab-on-a-chip, and molecular diagnostics demand specialized packaging to protect sensitive reagents and components. For instance, PCR test kits require moisture-resistant and temperature-controlled packaging to prevent degradation of enzymes and primers. As diagnostics become more sophisticated, packaging solutions must evolve to meet stringent regulatory and functional requirements.

Stringent regulatory standards play a crucial role in shaping the IVD packaging market. Regulatory bodies such as the FDA and EMA mandate strict guidelines to ensure packaging safety, sterility, and traceability. For example, IVD packaging must comply with ISO 13485 and CE marking for quality management and product safety. The shift toward sustainable packaging materials also influences market trends, as manufacturers explore biodegradable and recyclable options without compromising sterility.

Moreover, the expansion of diagnostic testing in emerging markets drives demand for cost-effective and scalable packaging solutions. Growing healthcare infrastructure in regions such as Asia-Pacific and Latin America increases the need for IVD tests, boosting packaging requirements. For example, India and China are witnessing a rise in local diagnostic manufacturing, prompting packaging suppliers to offer localized solutions. Furthermore, e-commerce and direct-to-consumer testing kits, such as at-home HIV or glucose tests, require user-friendly, leak-proof packaging to ensure safe delivery and usage, creating new opportunities for packaging innovation.

 Request a free sample copy or view report summary: In Vitro Diagnostic Packaging Market Report

In Vitro Diagnostic Packaging Market Report Highlights

• The bottles and vials segment accounted for the largest share of over 40.0% of the market in 2024 and is expected to grow at the fastest CAGR of 5.5% during the forecast period.

• Based on the application, the hospitals segment dominated the market in 2024 by accounting for the largest revenue share of over 43.0% in 2024.

• The academic institutes segment is projected to grow at the fastest CAGR of 5.4% over the forecast period of 2025 to 2030.

• Asia Pacific dominated the market space by registering the largest revenue market share of over 36.0% in 2024 and is anticipated to grow at the fastest CAGR of 5.5% during the forecast period.

• Amcor plc, AptarGroup Incorporated, Thermo Fisher Scientific Incorporated, Corning Incorporated, Greiner Holding AG, COMAR, LLC, WS Packaging Group, DWK Life Sciences, SCHOTT Poonawalla, SGD Pharma, and Stevanato are some of the key players operating in the in vitro diagnostic (IVD) packaging market.

In Vitro Diagnostic Packaging Market Segmentation

Grand View Research has segmented the in vitro diagnostic (IVD) packaging market based on product type, application, and region:

In Vitro Diagnostic Packaging Product Type Outlook (Revenue, USD Million, 2018 - 2030)

• Bottles and Vials

• Tubes

• Petri Dishes

• Labels & Stickers

• Others

In Vitro Diagnostic Packaging Application Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Laboratories

• Academic Institutes

• Others

In Vitro Diagnostic Packaging Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

• Asia Pacific

  • China

  • India

  • Japan

  • Australia

  • South Korea

• Central & South America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

List of Key Players in the In Vitro Diagnostic Packaging Market

• Amcor plc

• AptarGroup Incorporated

• Thermo Fisher Scientific Incorporated

• Corning Incorporated

• Greiner Holding AG

• COMAR, LLC

• WS Packaging Group

• DWK Life Sciences

• SCHOTT Poonawalla

• SGD Pharma

• Stevanato